Synta Pharmaceuticals is an innovative, agile biopharmaceutical company focused on research, development and commercialization of novel oncology medicines that have the potential to change the lives of cancer patients.

from http://www.syntapharma.com/about.php

Patents show all

668Applications385Issued

Clinical Trials show all

17Phase 114Phase 25Phase 1/Phase 22Phase 31Other

SEC Filings show all

8-K10610-Q3310-K11D2S-11

Contact Information

45 Hartwell Avenue
Lexington, MA 02421
United States

(781) 274-8200

    Overview

    Total FundingEmployeesLast Funding DateStatus
    $217,350,00051-1002015-04-01Ipo

    Crunchbase Investment Rounds

    DateAmountRoundValuationLead InvestorOther Investors
    2015-04-01$38,500,000Post_ipo_equity
    2010-01-08$23,100,000Post_ipo_equity
    2006-10-22$40,000,000Venture
    2004-01-14$50,000,000VentureDuquesne Capital Management, SunAmerica, Caxton Associates, Galleon Group, Gollust Management, Mountain Trail Investments
    2002-05-31$12,000,000Venture
    2004-12-07Venture
    2010-01-19$3,750,000Venture
    2003-04-21$50,000,000Venture

    SEC Form D Funding Events

    DateOfferedSoldType
    2004-12-07UnknownUnknownOther (Paper Filing)